Navigation Links
Healthscope to commercially launch Circadian's Cancers of Unknown Primary Diagnostic Test
Date:6/26/2012

ath due to cancer in Australia. In 2007, Cancer Council Australia estimated the incidence of CUP to be around 2900 case per annum; American Cancer Society estimated USA incidence at around 32,000 per annum and Cancer Research UK estimated UK incidence at 14,000 per annum.

Robert Klupacs, Circadian Managing Director and CEO stated, "We are absolutely delighted that after all of the efforts of the collaborative partners that CUPGUIDE™ will now be available to oncologists and pathologists. We are extremely hopeful that CUPGUIDE™ will have a major impact in significantly improving the clinical diagnosis of CUP."

Dr Keith Byron, Scientific Director of Healthscope's Advanced Pathology Division said, "Healthscope is proud and excited that after the extensive development program we have undertaken with our partners that we will now be able to provide this ground breaking diagnostic technology on a commercial basis. The test is an important addition to our existing business of providing diagnostic tools for doctors throughout our 43 hospitals and the health care industry in general."

Prof David Bowtell, Head of the Cancer Genomics Program at the Peter MacCallum Cancer Centre and a co-inventor of the diagnostic methodology added, "The approach was initially developed in our lab several years ago but the assay needed to be made more generally available.  Circadian and Healthscope have been critical to taking the work forward and it is very gratifying that this product of our translational research efforts will be made available to clinicians throughout the region. The concept of personalising treatments for patients based on highly specialised diagnostics is now very well accepted in oncology and has been shown to have significant patient benefit. We believe that the assay will lead to earlier diagnosis, improved treatment outcomes and enhanced quality of life for patients." 

Dr Adam Kowalczyk, Leader of Diagnostic Genomics
'/>"/>

SOURCE Circadian Technologies Limited
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. PeriGen, Inc. Launches Consumer Safety Campaign to Raise Awareness of Dangerous Birth Complication
2. Varian X-Ray Products Business Launches On-Line Product Finder for Customers
3. Frost & Sullivan: Launch of New Classes of Oral Antidiabetic Drugs by 2014 will Uplift Prospects for the European Diabetes Therapeutics Market
4. Konica Minolta Sensing America Launches Spanish Website in Support of Growing Demand In Latin American Countries
5. Nouveau Life Pharmaceuticals (NOUV) to Launch Affiliate Sales Program
6. The Michael J. Fox Foundation Launches The $14 Million-Edmond J. Safra Core Programs for PD Research
7. Lifescript Launches New Online Asthma Health Center
8. AUA Foundation Launches Campaign to Address Stigma of Overactive Bladder
9. Office Star to Launch Safety Campaign at The Mobility Roadshow
10. Smith & Nephew launches two plating systems for foot and ankle surgeons at AOFAS annual meeting in San Diego
11. Lilly Diabetes Launches 8th Annual Diabetes Summer Camp Tour With Olympian Kris Freeman
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... BUENA, N.J., March 2, 2015  IGI Laboratories, Inc. (NYSE ... announced its financial results for the fourth quarter and year ... to Date 2014 Highlights , Total revenues of ... of 104% over the same quarter in 2013 , ... 31, 2014, an increase of 85% over the same period ...
(Date:3/2/2015)... March 2, 2015  DURECT Corporation (Nasdaq: ... months ended December 31, 2014. Total revenues were $4.3 ... and for the three months ended December 31, 2013.  ... ended December 31, 2014 as compared to a net ... 2013.Total revenues were $19.4 million and net loss was ...
(Date:3/2/2015)... Click here for additional information on the ... DPLO ), the nation,s largest independent specialty pharmacy, announced ... 2014. All comparisons, unless otherwise noted, are to the quarter ... Quarter 2014 Highlights include: , Revenue of $612 ... of 208,000, an increase of 11% , Gross margin ...
Breaking Medicine Technology:IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 2IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 3IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 4IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 5IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 6IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 7IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 8IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 9IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 10IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 11IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 12DURECT Corporation Announces Fourth Quarter 2014 Financial Results and Update of Programs 2DURECT Corporation Announces Fourth Quarter 2014 Financial Results and Update of Programs 3DURECT Corporation Announces Fourth Quarter 2014 Financial Results and Update of Programs 4DURECT Corporation Announces Fourth Quarter 2014 Financial Results and Update of Programs 5DURECT Corporation Announces Fourth Quarter 2014 Financial Results and Update of Programs 6DURECT Corporation Announces Fourth Quarter 2014 Financial Results and Update of Programs 7DURECT Corporation Announces Fourth Quarter 2014 Financial Results and Update of Programs 8DURECT Corporation Announces Fourth Quarter 2014 Financial Results and Update of Programs 9DURECT Corporation Announces Fourth Quarter 2014 Financial Results and Update of Programs 10DURECT Corporation Announces Fourth Quarter 2014 Financial Results and Update of Programs 11DURECT Corporation Announces Fourth Quarter 2014 Financial Results and Update of Programs 12Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 2Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 3Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 4Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 5Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 6Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 7Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 8Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 9Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 10Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 11Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 12Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 13Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 14
... NEW YORK, Dec. 22, 2010 Delcath Systems, Inc. ... Company has submitted the remaining modules of its 505(b)(2) ... to the U.S. Food & Drug Administration (FDA). The ... based non-clinical data, to the FDA in late April ...
... (OTC Bulletin Board: RGIN ) a biotechnology company ... the health of damaged tissues and organs, will participate in ... Francisco. Randall McCoy, CEO of Regenicin, will present the company,s ... products to market. The Forum will bring ...
Cached Medicine Technology:Delcath Completes New Drug Application Submission to the FDA for the Chemosaturation Delivery System 2Delcath Completes New Drug Application Submission to the FDA for the Chemosaturation Delivery System 3Regenicin CEO to Present at OneMedForum Business Development and Finance Conference 2
(Date:3/2/2015)... Ticket Down is a reputable source for ... This popular site has reduced all ticket prices and ... added savings. , Parrotheads in the Los Angeles area ... at the Hollywood Bowl for the first time since ... 22nd and it will be in conjunction with Buffett's ...
(Date:3/2/2015)... York, New York (PRWEB) March 02, 2015 ... Publisher of Idoll Magazine, a medium for the model ... patrons can find, and buy Mango, Passion Fruit, Pink ... Tuesday, March 3rd, 2015, after 1pm. , At a ... Cosmetics has recently came under fire by announcing the ...
(Date:3/2/2015)... Alabama (PRWEB) March 02, 2015 Robins ... - In conjunction with Women in Construction Week (March ... Construction, or NAWIC) and National Women’s History Month, Robins ... commitment positively affect the company and the construction industry ... management team, to the dozens of roles in between, ...
(Date:3/2/2015)... (PRWEB) March 02, 2015 The Workgroup ... authority on the use of health IT to create ... paper, “ICD-10 Testing for Small Providers.” The white paper ... a starting point for ICD-10 testing by focusing on ... to ensure compliance with the October 1, 2015 implementation ...
(Date:3/2/2015)... (PRWEB) March 02, 2015 This year, the ... 2–8 and will provide opportunities for people across the country ... to help people with MS live their best lives. MS ... and to inspire others to join the Society’s vision of ... an unpredictable, often disabling disease of the central nervous system, ...
Breaking Medicine News(10 mins):Health News:Cheap Jimmy Buffett Tickets Hollywood Bowl: Ticket Down Slashes Prices on Jimmy Buffett Tickets at the Hollywood Bowl in Los Angeles/Hollywood, CA 2Health News:Sex Sells! A Newly Minted Organic Bodycare Brand Courts Controversy at a Cost 2Health News:Robins & Morton Recognizes Women In Construction 2Health News:WEDI Releases New White Paper on ICD-10 Testing for Small Providers 2Health News:Every Connection Counts During MS Awareness Week 2Health News:Every Connection Counts During MS Awareness Week 3Health News:Every Connection Counts During MS Awareness Week 4
... Clement Resigns; Board Appoints Paul Hamelin as President , ... Nov. 19 Savient Pharmaceuticals, Inc. (Nasdaq: ... has formed a BLA Oversight Committee ("the Committee")to oversee ... pegloticase, effective immediately. The Committee will be comprised of ...
... EAGAN, Minn., Nov. 19 Blue Cross and Blue ... up to $650,000 in,additional funds from its tobacco settlement ... next year. Eight local organizations have been,selected to work ... help improve,eating habits and reduce illness and costs related ...
... This month the hit television,show ,Living in Style, will ... Style, is a half-hour news magazine television,series and is ... ability to reduce body fat and increase lean muscle, ... brand of health supplements to,the consumer and utilizes Clarinol(TM) ...
... the,oath of "Primum non nocere" in medical school, a Latin phrase ... While no doctor intends to harm a patient, even the ... never happen. Yet there are medical mistakes so serious, so outrageous,that ... , What could possibly go ...
... Historic nonprofit offers help to SF neighborhood with highest citywide ... SAN FRANCISCO, Nov. 19 On World Diabetes ... blood sugar check ups, as well as diabetic foot and ... free massages to San Francisco,s poor and homeless. St. Anthony,s ...
... and Manage Personal Profiles. , ... Pleasanton, CA (PRWEB) ... template that allows users of its PXT wireless information technology to ... their mobile phones and accessed by other PXT users in the ...
Cached Medicine News:Health News:Savient's Board of Directors Forms a Board Committee to Oversee the Regulatory and Pre-Launch Activities for Pegloticase 2Health News:Savient's Board of Directors Forms a Board Committee to Oversee the Regulatory and Pre-Launch Activities for Pegloticase 3Health News:Savient's Board of Directors Forms a Board Committee to Oversee the Regulatory and Pre-Launch Activities for Pegloticase 4Health News:Savient's Board of Directors Forms a Board Committee to Oversee the Regulatory and Pre-Launch Activities for Pegloticase 5Health News:Savient's Board of Directors Forms a Board Committee to Oversee the Regulatory and Pre-Launch Activities for Pegloticase 6Health News:Savient's Board of Directors Forms a Board Committee to Oversee the Regulatory and Pre-Launch Activities for Pegloticase 7Health News:Savient's Board of Directors Forms a Board Committee to Oversee the Regulatory and Pre-Launch Activities for Pegloticase 8Health News:Blue Cross Teams up With Eight Groups to Address Obesity, Lower Minnesotans' Health Risks by Promoting Healthy Eating 2Health News:Blue Cross Teams up With Eight Groups to Address Obesity, Lower Minnesotans' Health Risks by Promoting Healthy Eating 3Health News:Clarinol(TM) CLA and Puregels(R) Featured on Hit Television Show 'Living in Style' 2Health News:Clarinol(TM) CLA and Puregels(R) Featured on Hit Television Show 'Living in Style' 3Health News:Insure.com Examines Major Medical Mistakes Called 'Never Events' 2Health News:Turkey Tips, Massage, and a Blood Test: St. Anthony's Celebrates Diabetes Day in New Green Clinic 2Health News:Zurado's PXT Wireless Technology Provides Users with On-The-Spot Information About Nearby People 2Health News:Zurado's PXT Wireless Technology Provides Users with On-The-Spot Information About Nearby People 3Health News:Zurado's PXT Wireless Technology Provides Users with On-The-Spot Information About Nearby People 4
Aplicare's Prep Pads offer convenience, low cost, ease of use. The medium size is appropriate for most applications. Each package is terminally sterilized, ensuring the safest possible product for th...
Aplicare's Prep Pads offer convenience, low cost, ease of use. The medium size is appropriate for most applications. Each package is terminally sterilized, ensuring the safest possible product for th...
IV Prep Swab Sticks are effective, easy to apply, dries quickly and reduces bacterial contaminations. They are ideal for preparation of the skin prior to a ventipuncture or injection....
... Plus PVP-I Scrub swabsticks is ... cleanser containing to prevent dryness. ... solution equivalent to 0.75% available ... kill skin surface pathogens, including ...
Medicine Products: